---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-074233"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:09:50.270522+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics stockholders elect directors, ratify KPMG at 2024 annual meeting

## Summary
- Annual meeting held June 12, 2024; 28,359,271 shares (81.71%) present or represented.
- Brian Corvese and Peter Behner elected as Class III directors for three-year terms.
- Ratification of KPMG LLP as independent auditor for FY2024 approved with 28,242,636 votes for.
- Broker non-votes of 3,364,923 on director elections and none on auditor ratification.

## SEC filing metadata
- accession: 0000950170-24-074233
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000095017024074233/0000950170-24-074233-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000095017024074233/inkt-20240612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-074233
- JSON: https://secwatch.observer/filing/0000950170-24-074233.json
- Plain text: https://secwatch.observer/filing/0000950170-24-074233.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.